US ramps up vaccine effort as more options in pipeline
A huge U.S. study of another COVID-19 vaccine candidate got underway Monday as states continue to roll out scarce supplies of the first shots to a nation anxiously awaiting relief from the catastrophic outbreak.
Public health experts say more options in addition to thetwovaccinesnowbeing dispensed — one made by Pfizer and its German partner BioNTech, the other by Moderna — are critical to amassing enough shots for the country and theworld.
The candidate made by Novavax Inc. is the fifth to reach final-stage testing in the country. Some 30,000 volunteers are needed to prove if the shot— a different kind than its Pfizer and Moderna competitors — reallyworks and is safe.
“If you want to have enoughvaccine tovaccinate all the people in the U.S. who you’d like to vaccinate — up to 85% or more of the population — you’re going to need more than two companies,” Dr. Anthony Fauci, the top U.S. infectious- disease expert, said Monday.
The coronavirus is blamed for about nearly 1.8 million deaths worldwide, including more than 334,000in theU.S. This has been the deadliest month of the outbreak in the U.S., with about65,000deaths in December, according tothe COVID Tracking Project. The nation has repeatedly recorded more than 3,000 dead per day over the past fewweeks.
The U.S. could be facing a terrible winter: Despite warnings to stay home and avoid others over the holidays, nearly 1.3 million people went through the nation’s airports Sunday, the highest one- day total since the crisis took hold in theU.S. nine months ago.
The Trump administration’s Operation Warp
Speed expects to have shipped 20 million doses of the Pfizer andModerna vaccines to states by the beginningofJanuary, fewer than originally estimated to the frustration of states and health officials trying to schedule the shots.
There is no real-time tracking of how quickly people are getting the first of the two required doses. As of Saturday, the Centers for Disease Control and Prevention had reports of more than 1.9million vaccinations, outofmore than9.5 million doses shipped.
“Just because a vaccine arrives doesn’t mean we can put an on-the- spot clinic up and running,” said JennyBarta, a public health official in Carlton County, Minnesota.
But Tuesday, her agency aimstovaccinate100people in a drive-thru clinic for emergency medical workers that Barta hopes could become a model for larger attempts at mass vaccination. Nurses will wheel vaccine to cars lined up in a county-owned snowplow garage. Oncethedrivers get their shots, they willwait in parking spaces to be sure they don’t have an allergic reaction before heading home.
“Vaccinatingoneindividual at a time is how we’re going to work our way out of this pandemic,” she said.
Yet another worry hanging over the vaccine scramble: Will shots block a new variant of the coronavirus that emerged in Britain and appears to spread more easily? Fauci said that there is no evidence it could outsmart the vaccine andthatNational Institutes of Health researchers will be “looking at it very intensively” to be sure.
Novavax already has enrolled 15,000 people in a late-stage study in Britain and 4,000 in South Africa. The newest and largest study, funded by the U.S. government, will recruit volunteers at more than 115 sites in theU.S. and Mexico and target highrisk older adults along with volunteers from Black and Hispanic communities, which have been hit hard by the virus.
“We’ve got to protect our community and our people,” said the Rev. Peter Johnson, 75, a civil rights activist in Dallas who was among the first volunteers.